Alembic Pharmaceuticals appoints Mr. Manish Kejriwal as Independent Director Kumar Jeetendra | April 5, 2024 Alembic Pharmaceuticals Limited appoints Mr. Manish Kejriwal as an Independent Director of the company for the period of five consecutive years effective from March 31, 2024. Mr. Kejriwal brings over 30 years of experience in private equity investments and is currently the founder and Managing Partner of Kedaara Capital. Prior to founding Kedaara Capital, Mr. …
Alembic Pharma Wins USFDA Approval for Dapagliflozin Tablets Kumar Jeetendra | April 7, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapagliflozin Tablets, 5 mg and 10 mg. Alembic Pharmaceuticals Limited Gets USFDA Approval for Dapagliflozin Tablets The approved ANDA is therapeutically equivalent to the reference listed drug product …
Alembic Pharmaceuticals Limited Gets USFDA Nod for Fingolimod 0.5 mg Kumar Jeetendra | May 1, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fingolimod Capsules, 0.5 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis). Fingolimod is …
